News Hub | News Direct

All Industries


Article thumbnail News Release

Ceres Applauds Two SEC Rule Proposals Designed To Protect Investors With Stronger ESG Disclosures From Investment Funds and Advisors

Ceres

The sustainability nonprofit Ceres submitted comments today in support of the U.S. Securities and Exchange Commission’s (SEC) proposed rules which aim to strengthen protections and address increasing confusion and greenwashing concerns around the rapid growth of ESG-oriented funds. In recent years, investor demand for climate and ESG investing has increased tremendously. In response to this demand, asset managers have put forth a wide array of new investment products. This explosive growth has resulted in significant controversy in public discourse, including many assertions of funds overstating the extent to which they consider ESG factors—a phenomenon referred to as greenwashing. One proposal, Enhanced Disclosures by Certain Investment Advisers and Investment Companies about Environmental, Social, and Governance Investment Practices, requires U.S. investment companies and advisors to state whether they use ESG criteria and disclose data that shows how funds meet those criteria if they have them. The second proposal, Investment Company Names, would strengthen the fund names rule to give investors more confidence that a fund name reflects its composition. In its comment letter, Ceres recommends changes that would make it easier for asset managers to comply with these rules without diminishing their effect. There are also some places in the Enhanced Disclosures rule where the SEC may wish to extend these disclosure requirements to other types of funds in separate rule makings. Ceres applauds the SEC for these proposals that fit squarely within their well-established mandate to protect the U.S. investing public. “Ceres strongly supports the SEC’s efforts to address greenwashing by requiring new disclosures of funds that make climate- and ESG-related claims and ensuring that fund names and marketing materials use ESG terms in a legitimate manner,” said Steven Rothstein, Managing Director of the Ceres Accelerator for Sustainable Capital Markets at Ceres. “These disclosures and limitations will bolster investor confidence in ESG funds and allow investors to make more educated decisions. We’re especially pleased to see ESG funds would be required to disclose their greenhouse gas emissions.” Assets managed with a sustainable mandate in the U.S. grew to over $17 trillion in 2020. This shift in asset allocation is evidence of the growing understanding that ESG factors are significant drivers of long-term investment performance. An analysis of over 11,000 mutual funds and ETFs showed that funds incorporating ESG criteria provide comparable financial returns to traditional funds, with less downside risk. Ceres is a nonprofit organization working with the most influential capital market leaders to solve the world’s greatest sustainability challenges. The Ceres Accelerator for Sustainable Capital Markets is a center of excellence within Ceres that aims to transform the practices and policies that govern capital markets to reduce the worst financial impacts of the climate crisis. It spurs action on climate change as a systemic financial risk—driving the large-scale behavior and systems change needed to achieve a net-zero emissions economy through key financial actors including investors, banks, and insurers. The Ceres Accelerator also works with corporate boards of directors on improving governance of climate change and other sustainability issues. For more information, visit: Media Contact: Reginald Zimmerman View additional multimedia and more ESG storytelling from Ceres on 3blmedia.com

August 16, 2022 02:00 PM Eastern Daylight Time

Image
Article thumbnail News Release

Nokia Radio Technology To Enable AST SpaceMobile's Direct-to-Cell Phone Connectivity From Space

Nokia

Nokia wins five-year global 4G and 5G deal from AST SpaceMobile AST SpaceMobile plans to bring cellular connectivity directly to 4G and 5G devices via low Earth-orbiting satellites in collaboration with mobile network operators Nokia and AST SpaceMobile committed to finding real-world solutions to expand universal coverage and close the digital divide around the world ESPOO, Finland, August 16, 2022 /3BL Media/ - Nokia today announced that they have signed a five-year 5G deal with AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS) – the company building the first and only space-based cellular broadband network accessible directly by standard 4G or 5G mobile devices. Under the deal, Nokia and AST SpaceMobile will work to achieve their joint ambition to expand universal coverage and connect underserved communities around the world. The launch of AST SpaceMobile’s BlueWalker 3 test satellite later this year will kick off global testing with mobile network operators on six continents. AST SpaceMobile's mission is to eliminate the connectivity gaps faced by over five billion mobile subscribers worldwide and to bring cellular broadband to approximately half of the world's population who remain unconnected. Their approach will mean that subscribers outside the reach of cellular coverage could have access to broadband speeds without having to invest in specialized hardware and be able to roam from land networks to space networks for the first time. Through its mobile network operator relationships, AST SpaceMobile has entered into agreements and understandings with mobile network operators which collectively service over 1.8 billion cellular customers. Nokia’s AirScale Single RAN equipment aims to enable AST SpaceMobile in providing mobile services to new and existing subscribers in regions currently not served by terrestrial communication networks. This includes connecting devices globally on land, at sea, or in flight. Nokia will provide equipment from its comprehensive, energy-efficient AirScale portfolio including its AirScale base stations powered by its latest generation of Nokia’s ReefShark System-on-Chip (SoC) chipsets. AST SpaceMobile will benefit from Nokia’s modular baseband plug-in cards which add capacity where it is needed offering flexibility and efficiency. Nokia will also provide its NetAct solution for network management and seamless daily network operations as well as optimization and technical support services. “Connectivity should be considered an essential service like water, electricity, or gas. Everyone should be able to have access to universal broadband services that will ensure that no one is left behind,” said Tommi Uitto, President of Mobile Networks at Nokia. “Nokia has a long history of delivering connectivity solutions that have had a major and positive impact on society. We have worked closely with AST SpaceMobile on this important initiative for two years which seeks to provide crucial connectivity from space to underserved communities around the world. We are of course proud our technology is playing an important role in underpinning the networks.” AST SpaceMobile plans to launch its BlueWalker 3 satellite for testing in early to mid-September from Cape Canaveral, Florida. BlueWalker 3 is a low Earth orbiting satellite and has an aperture of approximately 64 square meters (693 square feet), which is designed to communicate directly with cellular devices via 3GPP standard frequencies. Ultimately, AST SpaceMobile is aiming to deploy approximately 100 satellites to achieve substantial global mobile coverage. “With the integration of Nokia’s AirScale system, AST SpaceMobile and Nokia are taking an important step toward closing connectivity gaps all over the world," said Scott Wisniewski, Chief Strategy Officer at AST SpaceMobile. “Nokia is supporting us with dozens of engineers and development professionals, including leading architecture research experts at Bell Labs, the world-renowned industrial research arm of Nokia. In the coming months, we are scheduled to launch our BlueWalker 3 test satellite into low Earth orbit, which has a 64-square meter phased array antenna designed for direct-to-cell connectivity. With this satellite, we plan to conduct testing all over the world with leading mobile network operators, leveraging Nokia's technology solutions on the ground.” Nokia is committed to equitable opportunity for all and access to education, healthcare, jobs, and community digital services. Nokia supports the 2025 targets set by The Broadband Commission for Sustainable Development that aims to ‘connect the other half’ in the next five years. They are involved in several projects underway around the world including in El Salvador and Kenya. These public/private initiatives are designed to bring public services such as schools and hospitals online. They are intended to vastly improve internet access and create the foundations that will enable everyone to participate in the digital economy. Resources Nokia AirScale Image 1 About Nokia At Nokia, we create technology that helps the world act together. As a trusted partner for critical networks, we are committed to innovation and technology leadership across mobile, fixed and cloud networks. We create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs. Adhering to the highest standards of integrity and security, we help build the capabilities needed for a more productive, sustainable, and inclusive world. About AST SpaceMobile AST SpaceMobile is building the first and only global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on our extensive IP and patent portfolio. Our engineers and space scientists are on a mission to eliminate the connectivity gaps faced by today's five billion mobile subscribers and finally bring broadband to the billions who remain unconnected. For more information, follow AST SpaceMobile on YouTube, Twitter, LinkedIn and Facebook. Watch this video for an overview of the SpaceMobile mission. Media Inquiries: Nokia Communications Email: press.services@nokia.com AST SpaceMobile Media: Brandyn Bissinger Email: press@ast-science.com AST SpaceMobile Investor: Scott Wisniewski Email: investors@ast-science.com View additional multimedia and more ESG storytelling from Nokia on 3blmedia.com

August 16, 2022 02:00 PM Eastern Daylight Time

Article thumbnail News Release

Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?

BioLife Sciences Inc

BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company update throughout the course of a two-year transformation. Over the course of the last two years, BioLife has gone through a number of changes evolving into a revamped corporate entity focused on disrupting various consumer verticals, with a specific focus on health and wellness. Let’s take a look at some of what the company has been up to over the last two years. BioLife Sciences is Born: In June of 2020, the OTC Markets public entity formerly known as Rhino Novi Inc. (RNOV) underwent a reverse merger transaction – changing its name and ticker symbol to BioLife Sciences Inc. (BLFE). While Rhino Novi originally focused on VOIP products, the newly formed BioLife would focus on developing and marketing disruptive technologies to a variety of consumer verticals. Harnessing the Antimicrobial Power of Copper? BioLife has reported it focused on the utilization of the natural antimicrobial power of copper and harnessing its innate benefits into everyday textiles. This dynamic elemental metal has a wide variety of beneficial traits, including being required by all plants and animals as a key mineral and nutrient necessary for survival. In the case of humans specifically, copper reportedly helps to boost red blood cell production, provides support to the immune system, and helps to keep nerve cells healthy. For plants, copper is a fundamental micronutrient that is a critical element of plant enzymes, it is essential for plants’ respiration, plays a key role in plant cell wall strength and contributes to the overall strength of the plant. More recently, copper has been shown to provide antimicrobial efficacy associated with copper alloy touch surfaces. Some hospital studies have shown copper’s effectiveness in lowering E.coli counts on brass doorknobs, as well as SARS-CoV-2, Rhinovirus Type 37, Rotavirus Strain WA, and Human Coronavirus 229E. BioLife says it has focused its attention on incorporating the power of copper into everyday products which are fabric-based and disruptive, in contrast to the market’s current offering. Some of these products in development include copper-infused fabric gardening pots, copper-infused gardening gloves, copper-infused microfiber towels and copper-infused air filters. What is MFusion? The company states that traditional copper-infused products that consumers will find on the market today provide limited-to-partial copper coverage. This means that there could are often gaps in the copper coverage, resulting in less-than-optimal results. BioLife addresses this problem with the introduction of their unique copper infusion process: MFusion. MFusion infuses copper into every sub-bundle of the fabric, providing more complete coverage. When copper is infused into textiles via MFusion, the resulting fabrics benefit from 100% evenly distributed copper coverage. MFusion can be applied to any textile – from t-shirts to air filters – with the result being total copper infusion. The 2022 Acquisition of Health Box LLC – What’s Next? In February of 2022, BioLife completed the acquisition of Health Box LLC – an Arizona-based orthomolecular medicine and natural health products company. By completing this acquisition - and appointing Nika Jaksic, Health Box’s founder, as the new COO, the company believes it has positioned itself to enter the orthomolecular and natural health products space. In order to facilitate the Company’s aggressive expansion plans, the Company filed for a Regulation A+ Tier 1 Offering. The SEC qualified BioLife and the Company is eligible to raise up to $20 million. If successful in its capital raise, BioLife states that they intend to pursue rapid expansion of its existing and contemplated product offerings, audits, and the potential of filling towards uplisting to the OTC Venture Market (OTCQB). This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products and disruptive technology. One of BioLife Sciences’ core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Contact Details BioLife Sciences ir@biolifesciences.com Company Website https://www.biolifesciences.com

August 16, 2022 01:25 PM Eastern Daylight Time

Article thumbnail News Release

Direct Relief Delivers Seven-Week Supply of Long-Acting Insulin to Ukraine, Donated by Lilly

Direct Relief

August 16, 2022 /3BL Media/ - Responding to a call for assistance from Ukraine’s Ministry of Health, Direct Relief has secured and delivered to Ukraine enough long-acting insulin to meet the country’s estimated need for seven-plus weeks. The insulin, manufactured and provided to Direct Relief by the drug maker Eli Lilly and Company, was delivered to Ukraine over the past two weeks and will be allocated by Ukraine’s Ministry of Health to hospitals, clinics, and programs treating people with diabetes around the country. There are 2.3 million adults living with diabetes in Ukraine in 2022 – one in every 14 adults – 40% of whom are undiagnosed, according to the International Diabetes Federation’s Diabetes Atlas. All people with Type 1 diabetes and roughly 30% of people with Type 2 diabetes require daily insulin injections, while many depend on other medications to control the condition. Direct Relief and its partners estimate that Ukraine needs 115,000 10 ml vials of long-acting insulin per month. In this single supply of medicine, Lilly provided 673,000 quick-injection pens, each containing 3 ml of long-acting insulin glargine, equivalent to 202,191 10 ml vials, or enough to cover Ukraine’s needs for more than seven weeks. When a person has diabetes, their body doesn’t make enough insulin to control their blood sugar level, making them susceptible to health problems including heart disease, blindness, lower-limb amputations and more. Diabetes is among the world’s most widespread and most harmful noncommunicable diseases. In 2021 alone, diabetes caused an estimated 6.7 million deaths and at least $966 billion in health expenditures worldwide, according to the IDF, which has worked closely with Direct Relief in planning and facilitating large-scale insulin donations to countries in crisis around the world. “IDF expresses its immense gratitude to our partner Direct Relief for the organization’s quick and efficient mobilization of resources to deliver medical supplies and aid to support Ukrainian citizens living with diabetes,” said Prof. Andrew Boulton, president of IDF. “In times of crises, when resources are scarce, caring for diabetes can be extremely difficult. People living with diabetes require uninterrupted access to the medicines and care they need to manage their condition and prevent life-threatening complications. IDF’s long-term partner Lilly has been incredibly generous in supporting people with diabetes affected by the war in Ukraine. We applaud this latest donation of insulin, which will help bolster the country’s supply of this essential medicine.” People with diabetes take long-acting insulins like the insulin glargine donated by Lilly once a day to provide a baseline insulin level in their blood. Most people who depend on injected insulin also need short-acting insulin to level their blood sugar after meals. “Lilly recognizes the challenges people continue to face in Ukraine in accessing essential medicines like insulin. This collaboration with Direct Relief is critical to ensuring our medicines reach the healthcare providers and patients who need them,” said Michael B. Mason, president of Lilly Diabetes. The huge charitable supply of insulin is the latest action in Direct Relief’s extensive aid for Ukrainians with diabetes since Russia invaded Ukraine on February 24. Since then, Direct Relief has secured and delivered 1.4 million insulin quick-injection pens, 733,800 insulin pen needles, 188,833 10 ml insulin vials, nearly 25,000 glucose meters with 400,000 test strips, and over 3.2 million oral diabetes tablets equivalent to almost 1.5 million daily defined doses. Direct Relief has also provided a $150,000 grant to the Ukrainian Diabetes Federation (UDF) for managing and distributing insulin and diabetes-related medical supplies and testing equipment. Under a bi-lateral partnership agreement, Ukraine’s Ministry of Health is working with Direct Relief to secure medicine donations from pharmaceutical manufacturers, leveraging Direct Relief’s existing relationships, smoothing the processes of securing the drugs, and ensuring their timely delivery. Lilly supplied the insulin to Direct Relief, which arranged cold-chain transportation to Kyiv to benefit Ukrainian patients. Since the war erupted, Ukraine’s government has been covering access to insulin for its population with diabetes. “Direct Relief is deeply grateful to Lilly for its leadership and commitment reflected in this donation for the people of Ukraine,” said Thomas Tighe. “Lilly’s support is an incredible example of what’s needed to address this crisis from a humanitarian standpoint.” Since Russia invaded Ukraine, Direct Relief has provided more than 900 tons of requested medical aid to Ukraine and neighboring countries hosting Ukrainian refugees. View additional multimedia and more ESG storytelling from Direct Relief on 3blmedia.com

August 16, 2022 01:15 PM Eastern Daylight Time

Image
Article thumbnail News Release

Alkermes Earns 2022 Best Place for Working Parents Designation

Alkermes

For the all the working parents at Alkermes, we recognize that there is no greater responsibility than being present for your family. That’s why we’re so proud to be listed as one of The Best Place for Working Parents® among Massachusetts businesses. We know that being family friendly is business friendly! View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com

August 16, 2022 01:15 PM Eastern Daylight Time

Image
Article thumbnail News Release

Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide

Quest Diagnostics

PHILADELPHIA & SECAUCUS, N.J., August 16, 2022 /3BL Media/ - Rite Aid (NYSE: RAD) announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing ( polymerase chain reaction or similar nucleic acid amplification test ) to help Rite Aid customers detect and prevent the spread of COVID-19. “PCR and other molecular diagnostic tests are the gold-standard for reliable COVID-19 testing. Our relationship with Rite Aid will extend our delivery of COVID-19 testing to more communities in the United States.” Quest is the world’s leading provider of diagnostic information services and a national leader in COVID-19 testing. The company has performed more than 69 million COVID-19 molecular tests since March 2020. Through the collaboration, Rite Aid and Bartell Drugs’ more than 2,350 stores, now offer access to Quest PCR testing, either through their drive-thru locations or the addition of at home specimen testing kits from stores without drive-thrus, doubling the access to PCR testing for adults and children over 2 years old. Both options require an appointment be made through the Quest website. Quest Diagnostics will provide results electronically to individuals through the MyQuest online portal and app. Customers can schedule to pick up a COVID-19 PCR testing kit with at-home specimen collection or schedule observed drive-thru collection at  https://www.riteaid.com/pharmacy/services/covid-19-testing where they will be directed to request a test through Quest’s consumer-initiated test platform QuestDirect™. Bartell Drugs customers may visit bartelldrugs.com/covid19-testing. Quest’s kits come with a prepaid FedEx envelope for overnight shipping to a Quest laboratory. Currently, the average time for Quest Diagnostics to provide a test result is one to two days. Result turnaround times can fluctuate with demand levels and vary by region and other factors. “As new variants spread throughout our communities, testing remains a critical tool as we continue to support our communities in the fight against COVID-19,” said Karen Staniforth, Chief Pharmacy Officer at Rite Aid. “Identifying COVID-19 infection helps individuals obtain the treatment they need while helping to prevent further spread of the disease. We are proud to collaborate with Quest to make testing easily accessible for our customers by expanding to all of our stores.” “As people continue to navigate the COVID-19 pandemic, individuals and families need access to convenient, affordable and quality diagnostic testing in order to engage in activities more safely and responsibly,” adds Cathy Doherty, Senior Vice President, Regional Businesses, Quest Diagnostics. “PCR and other molecular diagnostic tests are the gold-standard for reliable COVID-19 testing. Our relationship with Rite Aid will extend our delivery of COVID-19 testing to more communities in the United States.” PCR and other nucleic acid amplification tests are molecular diagnostic testing technologies. Unlike at-home antigen tests, they are performed in a laboratory. According to the CDC, NAAT is the gold standard for detection of SARS-CoV-2, and they may be useful in some cases in confirming an antigen test result. Customers should discuss their test results with their doctor. In addition to the molecular tests, Rite Aid locations continue to provide rapid, over-the-counter at-home antigen COVID-19 test kits for customers. For more information on Rite Aid’s COVID-19 test options, visit riteaid.com. Rite Aid also continues to provide COVID-19 vaccines and boosters to eligible customers. Customers can schedule a COVID-19 vaccine by visiting: https://www.riteaid.com/pharmacy/scheduler. All Rite Aid locations are able to dispense the oral medications, Paxlovid, and Lagevrio (molnupiravir), for treatment of COVID-19. For the latest information on Quest’s COVID-19 testing efforts, visit Quest Diagnostics Newsroom - News Releases. About Rite Aid Corporation Rite Aid is a full-service pharmacy that improves health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of vehicles that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiaries, Elixir, Bartell Drugs and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, consists of accredited mail and specialty pharmacies, prescription discount programs and an industry leading adjudication platform to offer superior member experience and cost savings. Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs more than 6,300 pharmacists and operates more than 2,350 retail pharmacy locations across 17 states. For more information, visit www.riteaid.com. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com For further information: Media: Terri Hickey, Phone: 717-975-5718, press@riteaid.com, Kim Goode, mediacontact@questdiagnostics.com View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com

August 16, 2022 01:00 PM Eastern Daylight Time

Article thumbnail News Release

EMERGE- Leaning Forward Into Action

DOW

By Karen S. Carter, Chief Human Resources Officer and Chief Inclusion Officer EMERGE is an extraordinary experience. It energizes me. It is powerful to see first-hand how ID&E is transforming the lives and work experiences of my colleagues. How do you make inclusion, diversity and equity (ID&E) take off and grow in a global company with people in 31 countries? How do you transform ID&E from a top-down corporate initiative to a grassroots effort, fueled by the passion and purpose of thousands of frontline employees? How do you get individuals and teams to become empowered champions of ID&E? You get them to EMERGE – literally and figuratively. You get them to attend EMERGE, Dow’s all-Employee Resource Group (ERG) conference. And you empower them to emerge as advocates and change-makers for ID&E. In May of this year, we held our third EMERGE conference and our first since the pandemic began. Consistent with the values of ID&E, any member of Team Dow could self-nominate to attend. People in all jobs from across the Company participated side-by-side with Dow’s senior-most leaders, including our CEO, Jim Fitterling. About 500 people in all attended from around the Dow world. And for the first time, we employed a hybrid model so that people could attend the event virtually and still engage in the interactive elements of the conference – including our Day of Service. In my opening remarks, I urged people to engage fully with an open mind and an open heart, and to openly share their ideas over the next three days. And to listen…to really listen to each other. Because EMERGE is not a passive experience. It is an activation. Its success requires people to stretch, to challenge themselves and each other (respectfully), and to be ready to personally make an impact. Because the real return on the investment of our time at EMERGE is what we do when we return to our daily work-life. How we pay our experience forward. How we lean forward to intentionally define the actions we will take, and how we inspire colleagues to do the same. Because forward means ID&E becomes a catalyst for achieving business priorities like employee attraction and retention, and accelerating Dow’s decarbonize and grow strategy. Forward means greater profitability, a more engaged workforce and even stronger corporate citizenship. Speakers at EMERGE ranged from our CEO to our president and chief financial officer, Howard Ungerleider who shared the business value of ESG, to a quality system technologist, Nicole George and Ting Jiang, a production director who talked about their personal journeys. Guest speakers included Wharton professor and best-selling author Adam Grant, members of our Board of Directors, Gaurdie Banister and Jill S. Wyant, and Shannon Sisler, senior vice president and chief people officer at Crocs, among others. Every speaker inspired us, challenged us and encouraged us along the three days of the conference to move forward. EMERGE is an extraordinary experience. It energizes me. It is powerful to see first-hand how ID&E is transforming the lives and work experiences of my colleagues. I heard it in the voices of the gentlemen who said that Dow’s new parental leave policy had changed their lives. I saw it in the eyes of a colleague who had been working for more than 30 years but said the last four have been the best because they were with Dow. I felt it when a colleague shared that she lost her father during COVID, but that Dow and her ERG had literally saved her life. By the close of EMERGE, we achieved a renewed sense of unity, shared purpose and a commitment to action. We emerged, 1,500 ID&E champions. We emerged moving forward, together. View additional multimedia and more ESG storytelling from DOW on 3blmedia.com

August 16, 2022 12:50 PM Eastern Daylight Time

Image
Article thumbnail News Release

International Paper Receives Governor's Safety Award

International Paper Company

We are honored to see our facilities recognized for achievements in health and safety. Earlier this month several of our Minnesota North American Container facilities received recognition during the Minnesota Governor’s Safety Awards. About International Paper International Paper (NYSE: IP) is a leading global supplier of renewable fiber-based products. We produce corrugated packaging products that protect and promote goods, and enable worldwide commerce, and pulp for diapers, tissue and other personal care products that promote health and wellness. Headquartered in Memphis, Tenn., we employ approximately 38,000 colleagues globally. We serve customers worldwide, with manufacturing operations in North America, Latin America, North Africa and Europe. Net sales for 2021 were $19.4 billion. Additional information can be found by visiting InternationalPaper.com. About International Paper - EMEA In Europe, Middle East & Africa (EMEA), International Paper focuses on the production and marketing of fiber-based packaging and pulp, employing approximately 4,200 people. As a leading supplier of high-quality corrugated containers for a multitude of applications, we serve customers throughout the region from our network of two recycled containerboard mills and 23 box plants in France, Italy, Morocco, Portugal and Spain. Pulp production is centered in Gdansk, Poland. Other products available from International Paper in the region include Kraft linerboard and recycled containerboard, as well as pulp. Corporate Website Our Renewable Future Community Engagement View additional multimedia and more ESG storytelling from International Paper Company on 3blmedia.com

August 16, 2022 12:45 PM Eastern Daylight Time

Image
Article thumbnail News Release

The Beverage Industry Environmental Roundtable Welcomes New Member LION

Beverage Industry Environmental Roundtable

August 16, 2022 /3BL Media/ -The Beverage Industry Environmental Roundtable (BIER) is a technical coalition of leading global beverage companies working together to advance environmental sustainability within the beverage sector. BIER aims to affect sector change through work focused on water stewardship, energy efficiency and climate change, beverage container recycling, sustainable agriculture, and ecosystem services. Joining members, Anheuser-Busch InBev, Bacardi, Beam Suntory, Brown-Forman, Carlsberg Group, The Coca-Cola Company, Constellation Brands, Diageo, Heineken, Keurig Dr Pepper, MillerCoors, Molson Coors, Ocean Spray Cranberries, PepsiCo, and Pernod Ricard, LION will be contributing to BIER’s collaborative approach of accelerating the development of sustainable solutions through beverage industry-specific data collection, methodologies, standard-setting, and best practice sharing. LION is a leading beverage company headquartered in Sydney, Australia and also has operations in New Zealand and the United States. LION produces, markets, sells and distributes alcoholic and non-alcoholic drinks and operates microbreweries. LION’s portfolio of beloved brands spans beer, cider, wine, spirits, and kombucha. LION’s sustainability approach aims to strengthen the resilience of the communities in which the company operates, champion responsible use of its products and ensures its environmental legacy has a positive impact now and for future generations. "BIER is delighted to welcome LION to its membership and benefit from their diversity of experience building environmental sustainability in their business, products and communities that they operate. Every BIER member brings a wealth of practical, pre-competitive technical knowledge that collectively enhances the impact that beverage companies can make in their markets and products, and we expect LION will be no exception. Their membership validates the value that BIER delivers to its members and our vision that the beverage industry is globally recognized as the leader in advancing environmental sustainability.” ~ Dan Pierce, Executive Director of BIER LION’s Group General Counsel and Head of External Relations and Sustainability Libby Davidson said: “At LION, we realise that as a large business with thousands of team members across the globe, and as the custodian of brands that hold a special place in the lives of millions more, what we say and do matters. We’re determined to use that power to produce immediate and lasting benefits for society and our environment,” Davidson said. “Joining BIER contributes to LION's ongoing sustainability journey, and builds a pathway to help us tackle some of the biggest environmental challenges we collectively face as a global industry.” Through market leadership of its members, BIER has positioned itself as the sustainable voice of the industry. These partnerships generate positive awareness among key stakeholders and consumers alike on efforts towards sustainable solutions. Media contacts: Dan Pierce - BIER Executive Director / Daniel.Pierce@anteagroup.us Julie Starr - BIER Communications Director / jurlaub@taigacompany.com Lizzy Bold – Senior External Relations Manager / Elizabeth.Bold@lionco.com About BIER BIER is a technical coalition of leading global beverage companies working together to advance environmental sustainability within the beverage sector. Formed in 2006, BIER is a common voice across the beverage sector, speaking to influence global standards on environmental sustainability aspects most relevant to the sector, affect change both up and down the supply chain and share best practices that raise the bar for environmental performance of the industry. By doing so, BIER is able to monitor data and trends, engage with key stakeholders, develop best practices, and guide a course of action for the future. BIER members include Anheuser-Busch InBev, Bacardi, Beam Suntory, Brown-Forman, Carlsberg Group, The Coca-Cola Company, Constellation Brands, Diageo, Heineken, Keurig Dr Pepper, LION, MillerCoors, Molson Coors, Ocean Spray Cranberries, PepsiCo, and Pernod Ricard. For more information, visit www.bieroundtable.com. About LION LION is a leading beverage company headquartered in Sydney, Australia. With origins dating back 180 years, LION is known for its commitment to quality, craftsmanship, community and sustainability. LION is a pioneer in brewing and continues to innovate across a range of adult beverages. Its core beer portfolio includes many locally loved brands such as XXXX, Little Creatures, James Squire, Emerson’s, Speights and Panhead, more recently adding international craft brands Fourpure, Magic Rock and New Belgium to the fold. LION also has an enviable portfolio of NZ wine brands, a premium fine wine business in North America and shareholdings in Four Pillars Gin and Remedy Kombucha. LION employs close to 3,500 people across Australia, New Zealand, and the United States. www.lionco.com View additional multimedia and more ESG storytelling from Beverage Industry Environmental Roundtable on 3blmedia.com

August 16, 2022 12:10 PM Eastern Daylight Time

Image
12345 ... 1586